Corporate Support
Sitemap

Features

Customer Services

Events

Terms of Use

Singapore
Malaysia

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,990.4
-14.5 (-0.48%)

 

  • STI Straits Times Index
    2,990.4
    -14.5 (-0.48%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,609.5
    -17.5 (-1.07%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    28,862.8
    288.9 (1.01%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,596.2
    29.8 (0.84%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    28,242.2
    -277.0 (-0.97%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,389.8
    16.4 (0.26%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 2,533.0M
  • Value: 1,299.5M
  • Rise: 162
  • Fall: 184
  • Unch: 433

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol

  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Oceanus^0.042+0.004
Jiutian Chemical0.105+0.005
Fu Yu0.310+0.030
Artivision Tech0.012+0.001
AusGroup0.036+0.004
Annica0.001-
Sembcorp Marine0.168-0.001
The Place Hldg0.055+0.004
Asiatic0.010+0.001
ISDN0.740+0.110

World Indices

World Indices
Name Last Change
Nasdaq 12,998.5 -114.1
HSI 28,862.8 +288.9
HSCEI 11,462.5 +142.0
Jakarta 6,389.8 +16.4
Nikkei 225 28,242.2 -277.0
SSE Comp 3,596.2 +29.9
Shanghai A 3,769.6 +31.3
Shanghai B 250.8 +0.1
KOSPI 3,013.9 -72.0

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help

  • Factsheet

  • Print

CYMABAY THERAPEUTICS INC CYMABAY THERAPEUTICS
Updated on 15 Jan 2021 (End of trading day)
Last (USD): 6.090 Change: -0.120 High: 6.300 Remarks: -
Change (%): -1.93 Low: 6.020
Open 6.170 Yesterday's Close 6.21
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 667,294 Cumulative Value
 
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -1.49241 Trailing EPS (USD) e -0.93846 NAV (USD) b 2.2738
PE a - Trailing PE f - Price / NAV b 2.6783
Dividend (USD) d - Cash In Hand (USD) g 0.6862 Issued & Paid-up Shares c 68,887,100
Dividend Yield (%) d - Price / Cash In Hand g 8.875 Treasury Shares h -
Market Cap (M) 419.522 Enterprise Value (M) 260.109
Piotroski F Score 0 Exchange Code CBAY Par Value ( $ ) n.a.
52 Weeks Volatility (%) 116.72 Free Float (%) 90.2
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 11 Aug 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 13 Jul 2015.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference CYMABAY THERAPEUTICS INC NASDAQ 419.522 - - 2.6783 -
Industry Biotechnology NASDAQ 3,148.275 491.448 - 7.5529 0.541
Local Peer AMGEN INC NASDAQ 142,916.668 18.225 19.439 13.0411 2.400
Local Peer GILEAD SCIENCES INC NASDAQ 79,386.055 14.739 62.607 4.5506 4.019
Local Peer VERTEX PHARMACEUTICAL NASDAQ 58,651.571 49.839 21.798 7.2111 -
Local Peer REGENERON PHARMACEUTICALS INC NASDAQ 55,266.223 26.121 17.511 5.4581 -
Local Peer ILLUMINA INC NASDAQ 54,947.100 54.837 86.124 11.6909 -
Local Peer MODERNA INC NASDAQ 51,303.802 - - 18.5897 -
Local Peer BIOGEN INC NASDAQ 42,446.811 7.208 8.352 3.9454 -
Local Peer ALEXION PHARMACEUTICAL INC NASDAQ 34,273.581 14.255 35.829 3.0947 -
Local Peer SEAGEN INC NASDAQ 33,491.840 - 70.896 14.8324 -
Local Peer BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS NASDAQ 31,460.377 - - 7.3377 -
Local Peer BIONTECH SE SPON ADS EACH REP 1 ORD SHS NASDAQ 24,195.995 - - 22.2419 -
Local Peer EXACT SCIENCES CORP NASDAQ 23,213.609 - - 9.9326 -
Other Local Peers INCYTE CORPORATION (NASDAQ), 10X GENOMICS INC (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), BIO-TECHNE CORP (NASDAQ), ABCELLERA BIOLOGICS INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), BRIDGEBIO PHARMA INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), NOVAVAX INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), ACCELERON PHARMA (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), EXELIXIS INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), ABCAM PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), SEER INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), IMMUNOVANT INC (NASDAQ), ARVINAS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), RELAY THERAPEUTICS INC (NASDAQ), FIBROGEN INC (NASDAQ), INSMED INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), ALKERMES PLC (NASDAQ), KYMERA THERAPEUTICS INC (NASDAQ), PRELUDE THERAPEUTICS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), VERACYTE INC (NASDAQ), ALLOVIR INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), XENCOR INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), REGENXBIO INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), VIELA BIO INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), SHATTUCK LABS INC (NASDAQ), NANTKWEST INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), TRANSLATE BIO INC (NASDAQ), PERSONALIS INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), NKARTA INC (NASDAQ), UNIQURE N.V. (NASDAQ), C4 THERAPEUTICS INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), GRACELL BIOTECHNOLOGIES INC SPON ADS EACH REP 5 ORD SHS (NASDAQ), BIONANO GENOMICS INC (NASDAQ), PURETECH HEALTH PLC SPON ADS EACH REP 10 ORD SHS (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), BIOATLA INC (NASDAQ), COMPASS PATHWAYS PLC UNSPON ADS REP 1 ORD SHS (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), PRECIGEN INC (NASDAQ), TRAVERE THERAPEUTICS INC (NASDAQ), IMMUNOGEN INC (NASDAQ), CYTOKINETICS INC (NASDAQ), ALECTOR INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), VAXCYTE INC (NASDAQ), DYNE THERAPEUTICS INC (NASDAQ), PASSAGE BIO INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), INHIBRX INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), ITEOS THERAPEUTICS INC (NASDAQ), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), 4D MOLECULAR THERAPEUTICS INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), EPIZYME INC (NASDAQ), MACROGENICS INC (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), TAYSHA GENE THERAPIES INC (NASDAQ), OMEROS CORP (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), CURIS INC (NASDAQ), COMPUGEN (NASDAQ), SIGILON THERAPEUTICS INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), MIMEDX GROUP INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), CORTEXYME INC (NASDAQ), HUMANIGEN INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC SPON ADS EACH REP 6 ORD SHS (NASDAQ), ATHIRA PHARMA INC (NASDAQ), KADMON HLDGS INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), AFFIMED N V (NASDAQ), VAXART INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), COGENT BIOSCIENCES INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), IMMATICS N V (NASDAQ), ANAPTYSBIO INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), FOGHORN THERAPEUTICS INC (NASDAQ), MERUS B V (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), ONCORUS INC (NASDAQ), ASPIRA WOMENS HEALTH INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), AGENUS INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), ARDELYX INC (NASDAQ), FREELINE THERAPEUTICS HLDGS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), AKOUOS INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), INVENTIVA SA SPON ADS EACH REP 1 ORD SHS (NASDAQ), AVROBIO INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), PANDION THERAPEUTICS INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), ATRECA INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), SPRUCE BIOSCIENCES INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), BIOVIE INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), OPTHEA LIMITED SPON ADS EACH REPR 8 ORD SHS (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), GERON CORP (NASDAQ), IVERIC BIO INC (NASDAQ), FORTE BIOSCIENCES INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), CHIMERIX INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), XBIOTECH INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), GREENWICH LIFESCIENCES INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), UROGEN PHARMA LTD (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), XOMA CORP (NASDAQ), SUMMIT THERAPEUTICS INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), VERASTEM INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), ATHERSYS INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), OCUGEN INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), NEXTCURE INC (NASDAQ), INMUNE BIO INC (NASDAQ), TREVENA INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), CABALETTA BIO INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), KAMADA LTD (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), LARIMAR THERAPEUTICS INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), BELLUS HEALTH INC (NASDAQ), CHECKMATE PHARMACEUTICALS INC (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), ADICET BIO INC (NASDAQ), MEDICINOVA INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), OTONOMY INC (NASDAQ), IMMUNOPRECISE ANTIBODIES LTD (NASDAQ), IMV INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), METACRINE INC (NASDAQ), CHIASMA INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), EVOGENE LTD (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), AXCELLA HEALTH INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), MEDICENNA THERAPEUTICS CORP (NASDAQ), SESEN BIO INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), GLYCOMIMETICS INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), LUMOS PHARMA INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), AZIYO BIOLOGICS INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), INFLARX N V (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), IMMUNOME INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), ENOCHIAN BIOSCIENCES INC (NASDAQ), CONTRAFECT CORP (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), SIO GENE THERAPIES INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), EQUILLIUM INC (NASDAQ), ORGENESIS INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), SYNLOGIC INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), CELYAD ONCOLOGY SPON ADS EACH REPR 1 ORD SHS (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), ARAVIVE INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), COHBAR INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), SAVARA INC (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), RECRO PHARMA INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), BIOCARDIA INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), ADVAXIS INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), VACCINEX INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), SOLIGENIX INC (NASDAQ), KIROMIC BIOPHARMA INC (NASDAQ), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), ATYR PHARMA INC (NASDAQ), PRECIPIO INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), CYCLACEL PHARMACEUTICALS INC (NASDAQ), LIXTE BIOTECHNOLOGY HOLDINGS INC (NASDAQ), AIKIDO PHARMA INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), ADITX THERAPEUTICS INC (NASDAQ), INMED PHARMACEUTICALS INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), HISTOGEN INC (NASDAQ), CYCLO THERAPEUTICS INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), GEOVAX LABS INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), SENESTECH INC (NASDAQ)
Global Peer CSL LTD ASX 121,705.545 38.805 38.805 12.8373 1.097
Global Peer WUXI BIO HKEx 427,265.896 371.673 296.731 28.6027 -
Global Peer BEIGENE HKEx 259,141.556 - - 7.7989 -
Global Peer SINO BIOPHARM HKEx 132,449.384 43.153 51.758 3.6749 0.757
Global Peer ZAI LAB-SB HKEx 118,744.646 - - 32.9154 -
Global Peer EMERGENT BIOSOLUTIONS INC NYSE 5,633.274 103.363 33.813 4.5012 -
Global Peer Lonza SGX 5,940.891 6.617 5.028 0.6269 4.784
Global Peer GENSCRIPT BIO HKEx 20,721.228 - - 2.8340 -
Global Peer ARCUS BIOSCIENCES INC NYSE 2,400.864 - - 4.4100 -
Global Peer 3SBIO HKEx 17,601.712 15.942 11.723 1.5047 -
Other Global Peers VIVA BIOTECH (HKEx), JACOBIO-B (HKEx), MYOVANT SCIENCES LTD (NYSE), ALPHAMAB-B (HKEx), JW THERAP-B (HKEx), POLYNOVO LIMITED (ASX), ASCENTAGE-B (HKEx), JHBP-B (HKEx), HAOHAI BIOTEC (HKEx), FRONTAGE (HKEx), MESOBLAST LTD (ASX), TELIX PHARMACEUTIC (ASX), SQZ BIOTECHNOLOGIES CO (NYSE), ACTINIUM PHARMACEUTICALS INC (NYSE American), DPHARMA (Bursa), KINTOR PHARMA-B (HKEx), OPTHEA LIMITED (ASX), SINOMAB BIO-B (HKEx), IMUGENE LIMITED (ASX), ASCLETIS-B (HKEx), LEE'S PHARM (HKEx), LINEAGE CELL THERAPEUTICS INC (NYSE American), 22ND CENTURY GROUP INC (NYSE American), ESSEX BIO-TECH (HKEx), IMMUTEP LTD (ASX), NANOVIRICIDES INC (NYSE American), NEXT SCIENCE LTD (ASX), ANTEOTECH LIMITED (ASX), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), ENZO BIOCHEM INC (NYSE), IBIO INC (NYSE American), CEL-SCI CORP (NYSE American), NEUREN PHARMACEUTICALS LTD (ASX), KAZIA THERAPEUTICS LIMITED (ASX), PALATIN TECHNOLOGIES INC (NYSE American), SYNTHETIC BIOLOGICS INC (NYSE American), BIONOMICS LTD (ASX), AIM IMMUNOTECH INC (NYSE American), UNI-BIO GROUP (HKEx), LEAF RESOURCES LTD (ASX), CYNATA THERAPEUTICS LTD (ASX), MEMPHASYS LTD (ASX), GENETIC TECHNOLOGIES (ASX), ARMATA PHARMACEUTICALS INC (NYSE American), REGENT PACIFIC (HKEx), ALTERITY THERAPEUTICS LIMITED (ASX), INDIA GLOBALIZATION CAPITAL INC (NYSE American), INVEX THERAPEUTICS LTD NPV (ASX), ORAGENICS INC (NYSE American), BIOTRON (ASX), CT ENTERPRISE (HKEx), PRESCIENT THERAPEUTICS LIMITED (ASX), CONSTELLATION TECHNOLOGIES LTD (ASX), Suntar Eco-City (SGX), PATRYS LIMITED (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), BIOSINO BIO-TEC (HKEx), CONTANGO ASSET MANAGEMENT LIMITED (ASX), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), REGENEUS LTD (ASX), ADALTA LTD (ASX), RHINOMED LIMITED (ASX), ACTINOGEN MEDICAL LTD (ASX), AMPLIA THERAPEUTICS LTD (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), CRYOSITE (ASX), HOLISTA COLLTECH LIMITED (ASX), NOVABAY PHARMACEUTICALS INC (NYSE American), NANOLLOSE LTD (ASX), ANATARA LIFESCIENCES LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), HAO WEN HLDGS (HKEx), FACTOR THERAPEUTICS LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.460
-7.02 %
10 Days -+0.250
+4.28 %
20 Days --0.650
-9.64 %
Medium Term Return 3 Months --2.370
-28.01 %
6 Months -+2.230
+57.77 %
1 Year -+4.070
+201.49 %
Long Term Return 2 Years --2.840
-31.80 %
3 Years --4.360
-41.72 %
5 Years -+5.110
+521.43 %
Annualised Return Annualised --
+44.10 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 1.210 - 9.060 Change From 1 Year Low +4.880 % Change From 1 Year Low (%) +403.31
Change From 1 Year High -2.970 % Change From 1 Year High (%) -32.78
2 Years Range 1.210 - 14.000 Change From 2 Years Low +4.880 % Change From 2 Years Low (%) +403.31
Change From 2 Years High -7.910 % Change From 2 Years High (%) -56.50
5 Years Range 0.820 - 15.590 Change From 5 Years Low +5.270 % Change From 5 Years Low (%) +642.59
Change From 5 Years High -9.500 % Change From 5 Years High (%) -60.94
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

CymaBay Therapeutics, Inc. is a clinical stage biopharmaceutical company, focused on developing and providing access to therapies for patients with liver and other chronic diseases with high unmet medical need. Its products include MBX-8025 and Arhalofenate, MBX-8025 aims to treat lipid and liver diseases while Arhalofenate intends to reduce gout flares and serum uric acid. The company was founded on October 5, 1988 and is headquartered in Newark, CA.

Historical Price Data

Date Open High Low Close Volume VWAP
15 Jan 2021 6.170 6.300 6.020 6.090 667,294 -
14 Jan 2021 6.080 6.235 6.080 6.210 649,818 -
13 Jan 2021 6.340 6.421 6.060 6.080 861,915 -
12 Jan 2021 6.550 6.730 6.300 6.360 674,539 -
11 Jan 2021 6.380 6.640 6.320 6.550 590,203 -
08 Jan 2021 6.270 6.720 6.240 6.410 1,328,041 -
07 Jan 2021 6.035 6.290 6.000 6.200 1,019,071 -
06 Jan 2021 5.740 6.080 5.700 5.920 1,157,464 -
05 Jan 2021 5.860 5.920 5.680 5.730 983,908 -
04 Jan 2021 5.830 6.060 5.670 5.840 1,241,558 -
31 Dec 2020 5.850 5.930 5.665 5.740 4,250,310 -
30 Dec 2020 5.845 6.005 5.660 5.880 1,235,452 -
29 Dec 2020 6.140 6.140 5.640 5.730 1,404,805 -
28 Dec 2020 6.510 6.585 5.780 6.160 2,714,141 -
24 Dec 2020 6.570 6.680 6.470 6.520 329,419 -
23 Dec 2020 6.580 6.720 6.340 6.580 1,115,337 -
22 Dec 2020 6.820 6.980 6.560 6.580 1,050,833 -
21 Dec 2020 6.820 6.980 6.630 6.740 2,041,442 -
18 Dec 2020 7.080 7.160 6.820 6.950 1,580,201 -
17 Dec 2020 7.260 7.290 6.930 7.080 768,413 -
16 Dec 2020 7.350 7.400 7.090 7.190 671,176 -
15 Dec 2020 7.310 7.355 7.090 7.290 521,984 -
Summary
Current 2 Weeks
(04 Jan 2021 to 15 Jan 2021)		 5.830 6.730 5.670 6.090 9,173,811 -
Previous 2 Weeks
(17 Dec 2020 to 31 Dec 2020)		 7.260 7.290 5.670 5.740 16,490,353 -
4 Weeks from
(18 Nov 2020 to 16 Dec 2020)		 7.860 8.060 5.670 7.190 16,218,945 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.